Dermatology · Boston, MA
NPI
1437713344
Since 2019
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
221 Longwood Ave
Boston, MA, 02115
Phone (617) 732-4918
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
244 services
Medicare patients, 2024
62
Average age 71
Drug cost, 2024
$898K
402 prescriptions
Company payments, 2025
$141
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey S Smith was code 99214 (office e&m - established), 87 times for 46 patients. In total Jeffrey S Smith billed 244 services in 20 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 87 | 46 | $78.34 | $6,815 |
| 17003 Destruction Skin Lesion | Office | 34 | 11 | $1.65 | $56.1 |
| 17000 Destruction Skin Lesion | Office | 29 | 19 | $44.36 | $1,286 |
| 99213 Office E&M - Established | Office | 12 | 11 | $52.27 | $627 |
By year: 2023 $4,470 for 81 services; 2024 $14K for 244 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey S Smith prescribed most often to Medicare patients was Dupixent Pen (Dupilumab), with 57 prescriptions and refills. In total Jeffrey S Smith wrote 402 Medicare prescriptions that cost $898K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dupixent Pen Dupilumab | 57 | 62 | Under 11 | $226K |
| Methotrexate Methotrexate Sodium | 37 | 53 | Under 11 | $809 |
| Hydroxychloroquine Sulfate Generic | 27 | 37 | Under 11 | $851 |
| Ketoconazole Generic | 25 | 26 | 12 | $577 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 15 | 15 | Under 11 | $873 |
| Pentoxifylline Generic | 13 | 31 | Under 11 | $630 |
| Mycophenolate Mofetil Generic | 12 | 23 | Under 11 | $1,105 |
| Rinvoq Upadacitinib | 12 | 12 | Under 11 | $74K |
| Triamcinolone Acetonide Generic | 12 | 19 | Under 11 | $223 |
| Thalomid Thalidomide | 12 | 12 | Under 11 | $60K |
| Dupixent Syringe Dupilumab | 11 | 15 | Under 11 | $59K |
| Leucovorin Calcium Generic | 11 | 31 | Under 11 | $1,210 |
| Chloroquine Phosphate Generic | 11 | 11 | Under 11 | $2,107 |
Brand drugs: 152 claims; generic drugs: 250 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey S Smith $141 ($141 in general payments such as food, travel and fees) from 2 companies. The largest payer was Galderma Laboratories, L.P. with $107.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.